XOMA Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statements Detail (Tables)

Condensed Consolidated Financial Statements Detail (Tables)

6 Months Ended

Jun. 30, 2021

Condensed Consolidated Financial Statements Detail [Abstract]

Accrued and other liabilities consisted of the following (in thousands):


	June 30,		December 31,
	2021		2020
Accrued legal and accounting fees	$	454	$	351
Accrued incentive compensation		466		71
Accrued payroll and other		139		220
Total	$	1,059	$	642

Reconciliation of Numerator and Denominator Used in Calculation of Basic and Diluted Net (Loss) per Share Available to Common Stockholders

The following is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts):


	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Numerator
Net loss	$	(2,237)	$	(3,533)	$	(9,610)	$	(8,291)
Less: Series A accumulated dividends		(530)		—		(1,061)		—
Less: Series B accumulated dividends		(763)		—		(763)		—
Net loss available to common stockholders, basic and diluted	$	(3,530)	$	(3,533)	$	(11,434)	$	(8,291)

Denominator
Weighted average shares used in computing basic and diluted net loss per share available to common stockholders		11,285		10,824		11,263		10,292
Basic and diluted net loss per share of common stock	$	(0.31)	$	(0.33)	$	(1.02)	$	(0.81)

Outstanding Securities Considered Anti-Dilutive

The following table shows the weighted-average outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share attributable to common stockholders (in thousands):


	Three Months Ended June 30,		Six Months Ended June 30,
	2021	2020	2021	2020
Convertible preferred stock	5,003	5,196	5,003	5,726
Common stock options	377	564	318	578
Warrants for common stock	5	19	5	19
Total	5,385	5,779	5,326	6,323